Most cited papers from Clearside Biomedical (United States)
What are the most cited papers from Clearside Biomedical (United States)?
The most cited paper from Clearside Biomedical (United States) is "Efficacy and Safety of Suprachoroidal CLS-TA for Macular Edema Secondary to Noninfectious Uveitis" (Steven Yeh, Rahul N. Khurana, Milan Shah et al., 2020), with 188 citations. Next come "Treatment of Acute Posterior Uveitis in a Porcine Model by Injection of Triamcinolone Acetonide Into the Suprachoroidal Space Using Microneedles" (155) and "Suprachoroidal and Subretinal Injections of AAV Using Transscleral Microneedles for Retinal Gene Delivery in Nonhuman Primates" (147).
Showing 50 of 59 papers. Every paper with more than 9 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Efficacy and Safety of Suprachoroidal CLS-TA for Macular Edema Secondary to Noninfectious Uveitis Steven Yeh, Rahul N. Khurana, Milan Shah et al. · Ophthalmology | 10 Jan 2020 | 188 |
| 2 | Treatment of Acute Posterior Uveitis in a Porcine Model by Injection of Triamcinolone Acetonide Into the Suprachoroidal Space Using Microneedles Brian C. Gilger, Eva M. Abarca, Jacklyn H. Salmon et al. · Investigative Ophthalmology & Visual Science | 26 Mar 2013 | 155 |
| 3 | Suprachoroidal and Subretinal Injections of AAV Using Transscleral Microneedles for Retinal Gene Delivery in Nonhuman Primates Glenn C. Yiu, Sook Hyun Chung, Iris Natalie Mollhoff et al. · Molecular Therapy — Methods & Clinical Development | 20 Jan 2020 | 147 |
| 4 | Suprachoroidal Triamcinolone Acetonide for Retinal Vein Occlusion: Results of the Tanzanite Study Peter A. Campochiaro, Charles C. Wykoff, David M. Brown et al. · Ophthalmology Retina | 29 Sep 2017 | 115 |
| 5 | Innovative therapies for neovascular age-related macular degeneration Hasenin Al-khersan, Rehan M. Hussain, Thomas A. Ciulla et al. · Expert Opinion on Pharmacotherapy | 12 Jul 2019 | 114 |
| 6 | Tie-2/Angiopoietin pathway modulation as a therapeutic strategy for retinal disease Rehan M. Hussain, Ashley E. Neiweem, Viral S. Kansara et al. · Expert Opinion on Investigational Drugs | 12 Sep 2019 | 112 |
| 7 | Prevalence and characteristics of smokers at 30 Pacific Northwest colleges and universities Beti Thompson, Gloria D. Coronado, Lu Chen et al. · Nicotine & Tobacco Research | 2007 | 107 |
| 8 | Diabetic Retinopathy in the Aging Population: A Perspective of Pathogenesis and Treatment Sameer P. Leley, Thomas A. Ciulla, Ashay Dilip Bhatwadekar · Clinical Interventions in Aging | Jul 2021 | 100 |
| 9 | Suprachoroidal Corticosteroid Administration: A Novel Route for Local Treatment of Noninfectious Uveitis Debra Anne Goldstein, Diana Do, Glenn Noronha et al. · Translational Vision Science & Technology | 14 Dec 2016 | 92 |
| 10 | Suprachoroidally injected pharmacological agents for the treatment of chorio‐retinal diseases: a targeted approach Zohar Habot‐Wilner, Glenn Noronha, Charles C. Wykoff · Acta Ophthalmologica | 31 Jan 2019 | 87 |
| 11 | Suprachoroidal Delivery of Viral and Nonviral Gene Therapy for Retinal Diseases Viral S. Kansara, Leroy W. Muya, Chen-rei Wan et al. · Journal of Ocular Pharmacology and Therapeutics | 7 Apr 2020 | 83 |
| 12 | Cost-effectiveness of Voretigene Neparvovec-rzyl vs Standard Care forRPE65-Mediated Inherited Retinal Disease Scott J. Johnson, Marric Buessing, Thomas O’Connell et al. · JAMA Ophthalmology | 18 Jul 2019 | 80 |
| 13 | SUPRACHOROIDAL INJECTION OF TRIAMCINOLONE ACETONIDE, CLS-TA, FOR MACULAR EDEMA DUE TO NONINFECTIOUS UVEITIS Steven Yeh, Shree K. Kurup, Robert C. Wang et al. · Retina | 16 Aug 2018 | 76 |
| 14 | Genetics of Diabetic Retinopathy, a Leading Cause of Irreversible Blindness in the Industrialized World Ashay Dilip Bhatwadekar, Aumer Shughoury, Ameya Belamkar et al. · Genes | 31 Jul 2021 | 73 |
| 15 | Biomechanics of suprachoroidal drug delivery: From benchtop to clinical investigation in ocular therapies Shelley E. Hancock, Chen-rei Wan, Nathan E. Fisher et al. · Expert Opinion on Drug Delivery | 3 Jan 2021 | 71 |
| 16 | Suprachoroidal Triamcinolone Acetonide for Diabetic Macular Edema Charles C. Wykoff, Rahul N. Khurana, Shaun I.R. Lampen et al. · Ophthalmology Retina | 4 May 2018 | 65 |
| 17 | Suprachoroidal Delivery of Small Molecules, Nanoparticles, Gene and Cell Therapies for Ocular Diseases Chen-rei Wan, Leroy W. Muya, Viral S. Kansara et al. · Pharmaceutics | 22 Feb 2021 | 62 |
| 18 | Estimation of impact of RPE65-mediated inherited retinal disease on quality of life and the potential benefits of gene therapy Andrew J. Lloyd, Natalia Piglowska, Thomas A. Ciulla et al. · British Journal of Ophthalmology | 18 Jan 2019 | 61 |
| 19 | Suprachoroidal CLS-TA plus Intravitreal Aflibercept for Diabetic Macular Edema Mark Barakat, Charles C. Wykoff, Víctor H. González et al. · Ophthalmology Retina | 20 Aug 2020 | 57 |
| 20 | Choroidal Changes After Suprachoroidal Injection of Triamcinolone Acetonide in Eyes With Macular Edema Secondary to Retinal Vein Occlusion Alex S. Willoughby, Vivian S. Vuong, David Cunefare et al. · American Journal of Ophthalmology | 2 Dec 2017 | 57 |
| 21 | Anti-integrin therapy for retinovascular diseases Ashay Dilip Bhatwadekar, Viral S. Kansara, Qianyi Luo et al. · Expert Opinion on Investigational Drugs | 13 Jul 2020 | 56 |
| 22 | Phosphorodiamidates as a Promising New Phosphate Prodrug Motif for Antiviral Drug Discovery: Application to Anti-HCV Agents Christopher McGuigan et al. · Journal of Medicinal Chemistry | 31 Oct 2011 | 54 |
| 23 | Host Immune Responses after Suprachoroidal Delivery of AAV8 in Nonhuman Primate Eyes Sook Hyun Chung, Iris Natalie Mollhoff, Alaknanda Mishra et al. · Human Gene Therapy | 15 Jan 2021 | 53 |
| 24 | BRAMA: A New Graphic Animation Tool for B Models Thierry Servat · Lecture notes in computer science | 2006 | 52 |
| 25 | Extension study of the safety and efficacy of CLS-TA for treatment of macular oedema associated with non-infectious uveitis (MAGNOLIA) Rahul N. Khurana, Pauline Townsend Merrill, Steven Yeh et al. · British Journal of Ophthalmology | 12 Mar 2021 | 48 |
| 26 | Disease progression pathways of wet AMD: opportunities for new target discovery Amber T. Wolf, Alon Harris, Francesco Oddone et al. · Expert Opinion on Therapeutic Targets | 2 Jan 2022 | 47 |
| 27 | The complement system: a novel therapeutic target for age-related macular degeneration Aumer Shughoury, Duriye Damla Sevgi, Thomas A. Ciulla · Expert Opinion on Pharmacotherapy | 11 Sep 2023 | 46 |
| 28 | The evolving therapeutic landscape of diabetic retinopathy Aumer Shughoury, Ashay Dilip Bhatwadekar, Denis Jusufbegovic et al. · Expert Opinion on Biological Therapy | 14 Aug 2023 | 43 |
| 29 | RNA therapeutics for retinal diseases Michael C. Gemayel, Ashay Dilip Bhatwadekar, Thomas A. Ciulla · Expert Opinion on Biological Therapy | 14 Dec 2020 | 41 |
| 30 | Suprachoroidal CLS-TA for non-infectious uveitis: an open-label, safety trial (AZALEA) Christopher Ryan Henry, Milan Shah, Mark Barakat et al. · British Journal of Ophthalmology | 5 Feb 2021 | 40 |
| 31 | Suprachoroidal Space Alterations Following Delivery of Triamcinolone Acetonide: Post-Hoc Analysis of the Phase 1/2 HULK Study of Patients With Diabetic Macular Edema Shaun I.R. Lampen, Rahul N. Khurana, Glenn Noronha et al. · Ophthalmic surgery, lasers & imaging retina | Sep 2018 | 39 |
| 32 | Molecular Genetic Mechanisms in Age-Related Macular Degeneration Aumer Shughoury, Duriye Damla Sevgi, Thomas A. Ciulla · Genes | 12 Jul 2022 | 38 |
| 33 | Clinical Characterization of Suprachoroidal Injection Procedure Utilizing a Microinjector across Three Retinal Disorders Chen-rei Wan, Barry M. Kapik, Charles C. Wykoff et al. · Translational Vision Science & Technology | 22 Oct 2020 | 38 |
| 34 | Visual Acuity in Retinal Vein Occlusion, Diabetic, and Uveitic Macular Edema Thomas A. Ciulla, Barry M. Kapik, Dilraj Singh Grewal et al. · Ophthalmology Retina | 30 Oct 2020 | 35 |
| 35 | Suprachoroidal Injection of Triamcinolone Acetonide Suspension: Ocular Pharmacokinetics and Distribution in Rabbits Demonstrates High and Durable Levels in the Chorioretina Leroy W. Muya, Viral S. Kansara, Megan E. Cavet et al. · Journal of Ocular Pharmacology and Therapeutics | 11 Apr 2022 | 33 |
| 36 | Microinjection via the suprachoroidal space: a review of a novel mode of administration Thomas A. Ciulla · The American Journal of Managed Care | Nov 2022 | 32 |
| 37 | A Smart Mobile Application to Monitor Visual Function in Diabetic Retinopathy and Age-Related Macular Degeneration: The CLEAR Study Rahul N. Khurana, Carol Hoang, Arshad M. Khanani et al. · American Journal of Ophthalmology | 5 Apr 2021 | 31 |
| 38 | Evaluation of Long-Lasting Potential of Suprachoroidal Axitinib Suspension Via Ocular and Systemic Disposition in Rabbits Viral S. Kansara, Leroy W. Muya, Thomas A. Ciulla · Translational Vision Science & Technology | 15 Jun 2021 | 28 |
| 39 | Intraocular Distribution and Targeting of Triamcinolone Acetonide Suspension Administered Into the Suprachoroidal Space Henry F. Edelhauser, Rozemarijn S Verhoeven, Brian E. Burke et al. · Investigative Ophthalmology & Visual Science | 30 Apr 2014 | 26 |
| 40 | Suprachoroidal delivery enables targeting, localization and durability of small molecule suspensions Viral S. Kansara, Shelley E. Hancock, Leroy W. Muya et al. · Journal of Controlled Release | Sep 2022 | 25 |
| 41 | Investigational plasma kallikrein inhibitors for the treatment of diabetic macular edema: an expert assessment Ashay Dilip Bhatwadekar, Viral S. Kansara, Thomas A. Ciulla · Expert Opinion on Investigational Drugs | 27 Jan 2020 | 25 |
| 42 | Suprachoroidally Delivered DNA Nanoparticles Transfect Retina and Retinal Pigment Epithelium/Choroid in Rabbits Viral S. Kansara, Mark J. Cooper, Ozge Sesenoglu‐Laird et al. · Translational Vision Science & Technology | 15 Dec 2020 | 24 |
| 43 | A Randomized, Double-Masked, Multicenter Trial of Topical Acrizanib (LHA510), a Tyrosine Kinase VEGF-Receptor Inhibitor, in Treatment-Experienced Subjects With Neovascular Age-Related Macular Degeneration Stephen H. Poor, Georges Weissgerber, Christopher M. Adams et al. · American Journal of Ophthalmology | 2 Mar 2022 | 21 |
| 44 | Anatomic Biomarkers of Macular Edema Associated with Retinal Vein Occlusion Thomas A. Ciulla, Barry M. Kapik, Allen Y. H. Hu et al. · Ophthalmology Retina | 30 Jun 2022 | 20 |
| 45 | Challenges of Cost-Effectiveness Analyses of Novel Therapeutics for Inherited Retinal Diseases Thiran Jayasundera, Rebhi Abuzaitoun, Gabrielle D. Lacy et al. · American Journal of Ophthalmology | 22 Aug 2021 | 20 |
| 46 | Safety and Tolerability of Suprachoroidal Axitinib Injectable Suspension, for Neovascular Age-related Macular Degeneration; Phase I/IIa Open-Label, Dose-Escalation Trial Mark Barakat, David M. Brown, Allen Hu et al. · Ophthalmology Science | 25 Jul 2024 | 18 |
| 47 | Optical Coherence Tomography Anatomic and Temporal Biomarkers in Uveitic Macular Edema Thomas A. Ciulla, Barry M. Kapik, Mark Barakat et al. · American Journal of Ophthalmology | 2 Nov 2021 | 18 |
| 48 | Suprachoroidal triamcinolone acetonide versus rescue therapies for the treatment of uveitic macular oedema: A post hoc analysis of PEACHTREE Michael A. Singer, Pauline Townsend Merrill, Steven Yeh et al. · Clinical and Experimental Ophthalmology | 6 Nov 2021 | 18 |
| 49 | Suprachoroidal CLS-TA with and without Systemic Corticosteroid and/or Steroid-Sparing Therapy: A Post-Hoc Analysis of the Phase 3 PEACHTREE Clinical Trial Pauline Townsend Merrill, Christopher Ryan Henry, Quan Dong Nguyen et al. · Ocular Immunology and Inflammation | 18 Aug 2021 | 18 |
| 50 | Synchronous fluorescence spectroscopy of dissolved organic matter in surface waters: Application to airborne remote sensing Anthony Vodacek · Remote Sensing of Environment | Dec 1989 | 18 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.